Andrew Spillane, MD FRACS BM BS

Professor
Melanoma Institute Australia,, United States

Presentation(s):

• 59: Validating the Use of Surrogate Endpoints to Assess the Survival Outcomes of Melanoma Patients in Clinical Trials

  Friday, March 24, 2023
  10:44 AM – 10:54 AM

  Disclosure information not submitted.